Arrivent BioPharma, Inc. (AVBP)
21.00
+1.80
(+9.38%)
USD |
NASDAQ |
Oct 23, 16:00
20.58
-0.42
(-2.00%)
After-Hours: 20:00
Arrivent BioPharma Price : 21.00 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 19.00 | 21.23 | 18.18 | 21.00 | 3.279M |
| Oct 22, 2026 | 18.93 | 19.68 | 18.78 | 19.20 | 843701.0 |
| Oct 21, 2026 | 19.07 | 19.44 | 18.68 | 19.12 | 1.489M |
| Oct 20, 2026 | 17.94 | 18.98 | 17.57 | 18.85 | 817836.0 |
| Oct 19, 2026 | 16.82 | 18.14 | 16.73 | 17.94 | 1.013M |
| Oct 16, 2026 | 16.86 | 17.23 | 16.48 | 16.66 | 1.334M |
| Oct 15, 2026 | 16.40 | 16.91 | 15.97 | 16.79 | 815703.0 |
| Oct 14, 2026 | 16.06 | 16.62 | 15.26 | 16.20 | 1.589M |
| Oct 13, 2026 | 16.28 | 16.72 | 15.95 | 16.09 | 1.969M |
| Oct 12, 2026 | 16.57 | 16.78 | 16.26 | 16.46 | 1.335M |
| Oct 09, 2026 | 16.59 | 17.76 | 16.49 | 16.73 | 1.732M |
| Oct 08, 2026 | 16.62 | 16.91 | 15.78 | 16.71 | 2.156M |
| Oct 07, 2026 | 15.24 | 17.34 | 14.97 | 16.89 | 4.335M |
| Oct 06, 2026 | 12.09 | 15.79 | 11.36 | 15.09 | 19.75M |
| Oct 05, 2026 | 28.00 | 28.70 | 27.02 | 28.46 | 494758.0 |
| Oct 02, 2026 | 29.26 | 29.33 | 27.80 | 28.27 | 507603.0 |
| Oct 01, 2026 | 29.99 | 30.64 | 28.81 | 28.93 | 591789.0 |
| Sep 30, 2026 | 29.69 | 30.90 | 29.65 | 30.28 | 712457.0 |
| Sep 29, 2026 | 29.30 | 30.05 | 28.80 | 29.54 | 780005.0 |
| Sep 28, 2026 | 28.38 | 29.90 | 28.02 | 29.30 | 1.017M |
| Sep 25, 2026 | 30.16 | 30.55 | 28.43 | 28.45 | 653154.0 |
| Sep 24, 2026 | 29.94 | 30.51 | 29.24 | 30.10 | 608956.0 |
| Sep 23, 2026 | 30.32 | 31.49 | 29.84 | 30.30 | 1.206M |
| Sep 22, 2026 | 30.22 | 30.50 | 29.56 | 30.32 | 389123.0 |
| Sep 21, 2026 | 29.17 | 31.16 | 28.20 | 29.74 | 936996.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| Price to Book Value | 2.766 |
| Earnings Yield | -17.53% |
| Market Cap | 1.015B |